They focused on 2.4 million people with diabetes, including 215,970 patients who used GLP-1 receptor agonists for treatment. The study mapped the effects of GLP-1 receptor agonists across the ...

The Global Healthy Living Foundation (GHLF) announced today the launch of Your Interactive Patient Guide to Hidradenitis Suppurativa (HS), a groundbreaking resource designed to empower individuals ...

The Global Healthy Living Foundation (GHLF) announced today the launch of Your Interactive Patient Guide to Hidradenitis Suppurativa ... simplifies the complex journey of managing HS by providing ...

Opzelura is under clinical development by Incyte and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData ... and non-continuous chronic treatment of mild to moderate atopic ...

he discusses the initial appearance of hidradenitis suppurativa (HS), explaining the ages at which the chronic, painful skin disease typically manifests. He also looks to the future of patient ...

A patient journey map is a useful tool to understand patient insights, for example, but fundamentally we need to go beyond clinical indicators and integrate emotional indicators too. In a recent ...

Brensocatib is under clinical development by Insmed and currently in Phase I for Hidradenitis Suppurativa. According to GlobalData ... lung infection and NTM lung infections caused by MAC in adult ...